Connection

THOMAS KOSTEN to Young Adult

This is a "connection" page, showing publications THOMAS KOSTEN has written about Young Adult.
Connection Strength

0.983
  1. Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo-controlled crossover laboratory study. Am J Addict. 2025 Jan; 34(1):7-14.
    View in: PubMed
    Score: 0.081
  2. Hospital Stay in Synthetic Cannabinoid Users With Bipolar Disorder, Schizophrenia, or Other Psychotic Disorders Compared With Cannabis Users. J Stud Alcohol Drugs. 2019 03; 80(2):230-235.
    View in: PubMed
    Score: 0.055
  3. Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial. Drug Alcohol Depend. 2014 Jul 01; 140:42-7.
    View in: PubMed
    Score: 0.040
  4. Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment. Drug Alcohol Depend. 2014 Mar 01; 136:36-42.
    View in: PubMed
    Score: 0.039
  5. Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia. Drug Alcohol Depend. 2013 Oct 01; 132(3):674-80.
    View in: PubMed
    Score: 0.037
  6. Interleukin 18 and cognitive impairment in first episode and drug na?ve schizophrenia versus healthy controls. Brain Behav Immun. 2013 Aug; 32:105-11.
    View in: PubMed
    Score: 0.037
  7. DBH gene as predictor of response in a cocaine vaccine clinical trial. Neurosci Lett. 2013 Apr 29; 541:29-33.
    View in: PubMed
    Score: 0.037
  8. BDNF Val66Met variant and smoking in a Chinese population. PLoS One. 2012; 7(12):e53295.
    View in: PubMed
    Score: 0.036
  9. Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients. J Clin Psychiatry. 2012 Jul; 73(7):1025-33.
    View in: PubMed
    Score: 0.035
  10. Plasma total antioxidant status and cognitive impairments in schizophrenia. Schizophr Res. 2012 Aug; 139(1-3):66-72.
    View in: PubMed
    Score: 0.035
  11. Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms. Addiction. 2012 Jan; 107(1):131-41.
    View in: PubMed
    Score: 0.033
  12. Smoking and tardive dyskinesia in male patients with chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15; 35(7):1765-9.
    View in: PubMed
    Score: 0.033
  13. The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients. Schizophr Res. 2009 Sep; 113(2-3):151-7.
    View in: PubMed
    Score: 0.028
  14. The association between cannabis use and suicidal intensity in psychiatric inpatients. Am J Addict. 2025 Sep; 34(5):506-516.
    View in: PubMed
    Score: 0.021
  15. Use of Cigarettes and E-Cigarettes, Impulsivity, and Anxiety: Influences on Suicidal Ideation Among Youth and Young Adults in Texas. Nicotine Tob Res. 2024 12 23; 27(1):54-60.
    View in: PubMed
    Score: 0.021
  16. Transcranial Direct Current Stimulation Combined With Repetitive Transcranial Magnetic Stimulation for Depression: A Randomized Clinical Trial. JAMA Netw Open. 2024 11 04; 7(11):e2444306.
    View in: PubMed
    Score: 0.021
  17. Cognitive enhancing effect of rTMS combined with tDCS in patients with major depressive disorder: a double-blind, randomized, sham-controlled study. BMC Med. 2024 06 20; 22(1):253.
    View in: PubMed
    Score: 0.020
  18. A randomized trial of safety and pharmacodynamic interactions between a selective glucocorticoid receptor antagonist, PT150, and ethanol in healthy volunteers. Sci Rep. 2021 05 10; 11(1):9876.
    View in: PubMed
    Score: 0.016
  19. Internet Addiction Increases in the General Population During COVID-19: Evidence From China. Am J Addict. 2021 07; 30(4):389-397.
    View in: PubMed
    Score: 0.016
  20. Cognitive Deficits and Clinical Symptoms with Hippocampal Subfields in First-Episode and Never-Treated Patients with Schizophrenia. Cereb Cortex. 2021 01 01; 31(1):89-96.
    View in: PubMed
    Score: 0.016
  21. Cingulate Cortex Structural Alterations in Substance Use Disorder Psychiatric Inpatients. Am J Addict. 2021 01; 30(1):72-79.
    View in: PubMed
    Score: 0.016
  22. Use of Guanfacine for Cannabis Use Disorder and Related Symptomology. Am J Addict. 2019 11; 28(6):455-464.
    View in: PubMed
    Score: 0.014
  23. Lofexidine in Combination With Oral Naltrexone for Opioid Use Disorder Relapse Prevention: A Pilot Randomized, Double-Blind, Placebo-Controlled Study. Am J Addict. 2019 11; 28(6):480-488.
    View in: PubMed
    Score: 0.014
  24. The effect of minocycline on amelioration of cognitive deficits and pro-inflammatory cytokines levels in patients with schizophrenia. Schizophr Res. 2019 10; 212:92-98.
    View in: PubMed
    Score: 0.014
  25. Insular resting state functional connectivity is associated with gut microbiota diversity. Eur J Neurosci. 2019 08; 50(3):2446-2452.
    View in: PubMed
    Score: 0.014
  26. Exenatide once weekly for smoking cessation: study protocol for a randomized clinical trial. Medicine (Baltimore). 2018 Jan; 97(2):e9567.
    View in: PubMed
    Score: 0.013
  27. Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study. J Neuropsychiatry Clin Neurosci. 2018; 30(1):66-76.
    View in: PubMed
    Score: 0.012
  28. Psychopathology and personality traits associated with driving while intoxicated in Beijing, China: Implications for interventions. Am J Addict. 2017 Jun; 26(4):374-378.
    View in: PubMed
    Score: 0.012
  29. The a-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individuals. Pharmacogenet Genomics. 2016 09; 26(9):428-35.
    View in: PubMed
    Score: 0.012
  30. Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study. Int J Neuropsychopharmacol. 2016 07; 19(7).
    View in: PubMed
    Score: 0.012
  31. Contribution of IL-10 and its -592 A/C polymorphism to cognitive functions in first-episode drug-naive schizophrenia. Brain Behav Immun. 2016 Oct; 57:116-124.
    View in: PubMed
    Score: 0.011
  32. Extensive white matter abnormalities and clinical symptoms in drug-naive patients with first-episode schizophrenia: a voxel-based diffusion tensor imaging study. J Clin Psychiatry. 2016 Feb; 77(2):205-11.
    View in: PubMed
    Score: 0.011
  33. Operationalizing NIMH Research Domain Criteria (RDoC) in naturalistic clinical settings. Bull Menninger Clin. 2016; 80(3):187-212.
    View in: PubMed
    Score: 0.011
  34. Inhibitory behavioral control: A stochastic dynamic causal modeling study comparing cocaine dependent subjects and controls. Neuroimage Clin. 2015; 7:837-47.
    View in: PubMed
    Score: 0.011
  35. Reinforcement sensitivity underlying treatment-seeking smokers' affect, smoking reinforcement motives, and affective responses. Psychol Addict Behav. 2015 Jun; 29(2):300-311.
    View in: PubMed
    Score: 0.010
  36. A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of JDTic. Neuropsychopharmacology. 2015 Aug; 40(9):2059-65.
    View in: PubMed
    Score: 0.010
  37. Inhibitory behavioral control: a stochastic dynamic causal modeling study using network discovery analysis. Brain Connect. 2015 Apr; 5(3):177-86.
    View in: PubMed
    Score: 0.010
  38. Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms. J Clin Psychopharmacol. 2014 Apr; 34(2):234-9.
    View in: PubMed
    Score: 0.010
  39. Association between DBH 19 bp insertion/deletion polymorphism and cognition in first-episode schizophrenic patients. Schizophr Res. 2013 Jul; 147(2-3):236-40.
    View in: PubMed
    Score: 0.009
  40. Low BDNF is associated with cognitive deficits in patients with type 2 diabetes. Psychopharmacology (Berl). 2013 May; 227(1):93-100.
    View in: PubMed
    Score: 0.009
  41. Gender differences in socio-demographic and clinical characteristics of methamphetamine inpatients in a Chinese population. Drug Alcohol Depend. 2013 Jun 01; 130(1-3):94-100.
    View in: PubMed
    Score: 0.009
  42. No association between the type 2 diabetes mellitus susceptibility gene, SLC30A8 and schizophrenia in a Chinese population. Hum Psychopharmacol. 2012 Jul; 27(4):392-6.
    View in: PubMed
    Score: 0.009
  43. Association of functional COMT Val108/Met polymorphism with smoking cessation in a nicotine replacement therapy. J Neural Transm (Vienna). 2012 Dec; 119(12):1491-8.
    View in: PubMed
    Score: 0.009
  44. Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychopathology. J Psychiatr Res. 2012 Aug; 46(8):1093-8.
    View in: PubMed
    Score: 0.009
  45. The dopamine b-hydroxylase 19 bp insertion/deletion polymorphism was associated with first-episode but not medicated chronic schizophrenia. J Psychiatr Res. 2012 Jun; 46(6):733-7.
    View in: PubMed
    Score: 0.009
  46. Differential cigarette-related startle cue reactivity among light, moderate, and heavy smokers. Addict Behav. 2012 Aug; 37(8):885-9.
    View in: PubMed
    Score: 0.009
  47. Noradrenergic a1 receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial. PLoS One. 2012; 7(2):e30854.
    View in: PubMed
    Score: 0.008
  48. Reduced plasma total antioxidant status in first-episode drug-naive patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 01; 35(4):1064-7.
    View in: PubMed
    Score: 0.008
  49. Behavioral effects of gamma-hydroxybutyrate in humans. Behav Pharmacol. 2010 Jul; 21(4):332-42.
    View in: PubMed
    Score: 0.008
  50. Stress enhances retrieval of drug-related memories in abstinent heroin addicts. Neuropsychopharmacology. 2010 Feb; 35(3):720-6.
    View in: PubMed
    Score: 0.007
  51. Diurnal variation in cue-induced responses among protracted abstinent heroin users. Pharmacol Biochem Behav. 2009 Jan; 91(3):468-72.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.